Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yip, J. W.
Right arrow Articles by Viberti, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yip, J. W.
Right arrow Articles by Viberti, G.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 45, Issue 12 1729-1733, Copyright © 1996 by American Diabetes Association


ARTICLES

Glomerular hyperfiltration in the prediction of nephropathy in IDDM: a 10-year follow-up study

JW Yip, SL Jones, MJ Wiseman, C Hill and G Viberti
Unit for Metabolic Medicine, United Medical and Dental Schools, Guy's Hospital, London, U.K.

Glomerular hyperfiltration has been proposed as an independent risk factor for the development of diabetic nephropathy in patients with IDDM. In a case-controlled prospective study of IDDM patients without albuminuria, serial glomerular filtration rate (GFR) measurements were performed over an observation period of 10 years. A group of 25 IDDM patients (20 men, 5 women; initial age, 29 [17-49] years) with glomerular hyperfiltration (GFR >135 ml x min(-1) x 1.73 m(-2)) were matched for age, sex, and duration of diabetes with 25 IDDM patients (20 men, 5 women; initial age, 30 [17-48] years) with glomerular normofiltration (GFR 83-135 ml x min(-1) x 1.73 m(-2)). GFR, urinary albumin excretion rate (AER), blood pressure, and glycated hemoglobin were measured at baseline and at 5, 8, and 10 years. The two groups had similar entry levels of blood pressure, AER, and glycated hemoglobin. Metabolic control was similar in the two groups during follow-up. The final GFR remained higher in the group with hyperfiltration (122 [109-135] vs. 103 [95-111] ml x min(-1) x 1.73 m(-2); P = 0.02) despite a nonsignificantly faster rate of fall of GFR compared with that of the control group (2.54 [1.20-3.88] vs. 1.50 [1.01-1.99] ml x min(-1) x year(-1); P = 0.14). A similar number of patients in each group progressed to either microalbuminuria or macroalbuminuria (n = 4 vs. n = 3) or developed hypertension (blood pressure, >160/95 mmHg; n = 3 vs. n = 4). End-of-study AER was, however, higher in the group with hyperfiltration (geometric mean [95% CI]: 18.9 [11.3-31.6] vs. 11.0 [8.1-15.0]; P = 0.05), and baseline glomerular hyperfiltration was an independent determinant of end-of-study blood pressure (P = 0.04). The strongest predictors of end-of-study AER and blood pressure were their baseline values (P < 0.04 and P < 0.01, respectively). In conclusion, levels of AER and blood pressure are the main risk factors for renal outcome, while glomerular hyperfiltration appears to play a lesser role.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
L. Gnudi, S. M. Thomas, and G. Viberti
Mechanical Forces in Diabetic Kidney Disease: A Trigger for Impaired Glucose Metabolism
J. Am. Soc. Nephrol., August 1, 2007; 18(8): 2226 - 2232.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
E. B. Sochett, D. Z.I. Cherney, J. R. Curtis, M. G. Dekker, J. W. Scholey, and J. A. Miller
Impact of Renin Angiotensin System Modulation on the Hyperfiltration State in Type 1 Diabetes
J. Am. Soc. Nephrol., June 1, 2006; 17(6): 1703 - 1709.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. M. Steinke, A. R. Sinaiko, M. S. Kramer, S. Suissa, B. M. Chavers, M. Mauer, and for the International Diabetic Nephropathy Study G
The Early Natural History of Nephropathy in Type 1 Diabetes: III. Predictors of 5-Year Urinary Albumin Excretion Rate Patterns in Initially Normoalbuminuric Patients
Diabetes, July 1, 2005; 54(7): 2164 - 2171.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
S. Andersen, J. Brochner-Mortensen, and H.-H. Parving
Kidney Function During and After Withdrawal of Long-Term Irbesartan Treatment in Patients With Type 2 Diabetes and Microalbuminuria
Diabetes Care, December 1, 2003; 26(12): 3296 - 3302.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. Mauer and K. Drummond
The Early Natural History of Nephropathy in Type 1 Diabetes: I. Study Design and Baseline Characteristics of the Study Participants
Diabetes, May 1, 2002; 51(5): 1572 - 1579.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
G. Dahlquist, E.-L. Stattin, and S. Rudberg
Urinary albumin excretion rate and glomerular filtration rate in the prediction of diabetic nephropathy; a long-term follow-up study of childhood onset type-1 diabetic patients
Nephrol. Dial. Transplant., July 1, 2001; 16(7): 1382 - 1386.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1996 by the American Diabetes Association.